Related Experiment Video
Updated: Jan 17, 2026

Transthoracic Speckle Tracking Echocardiography for the Quantitative Assessment of Left Ventricular Myocardial Deformation
Published on: October 20, 2016
Subclinical myocardial dysfunction in essential thrombocythemia: role of global longitudinal strain
Aykut Demirkıran1, Cihan Aydın1, Hüseyin Orta1
1Department of Cardiology, Faculty of Medicine, Tekirdağ Namık Kemal University, Tekirdağ, Turkey.
Insights
Essential thrombocytosis (ET) may reduce cardiac global longitudinal strain (GLS). The JAK2 mutation is associated with reduced GLS in ET patients, indicating potential cardiac implications.
Area of Science:
- Cardiology
- Hematology
- Oncology
Background:
- Essential thrombocytosis (ET) is a myeloproliferative neoplasm.
- Cardiac involvement in ET is not fully understood.
- Global longitudinal strain (GLS) is a sensitive measure of cardiac function.
Purpose of the Study:
- To evaluate cardiac global longitudinal strain (GLS) in patients with essential thrombocytosis (ET).
- To compare GLS between ET patients and healthy controls.
- To investigate the association between GLS and the JAK2 mutation in ET.
Main Methods:
- Transthoracic echocardiography was performed on 60 ET patients and 32 healthy controls.
- GLS and routine echocardiographic parameters were compared between groups.
- Logistic regression analysis was used to assess associations with GLS.
Main Results:
- ET patients exhibited significantly reduced GLS compared to controls (16.5 ± 2.4% vs. 22.5 ± 2.2%, p=0.024).
- Reduced GLS (≤18%) was more prevalent in ET patients with the JAK2 mutation (81.1% vs. 21.7%, p<0.001).
- The JAK2 mutation was independently associated with reduced GLS (OR: 4.6, p=0.04).
Conclusions:
- Essential thrombocytosis may lead to reduced cardiac global longitudinal strain.
- The presence of the JAK2 mutation is linked to diminished GLS in ET patients.
- These findings suggest potential subclinical cardiac dysfunction in ET, particularly with JAK2 mutation.
Background:
The present study aimed to evaluate cardiac global longitudinal strain (GLS) in patients diagnosed with essential thrombocytosis (ET).
Research Design And Methods:
Patients diagnosed with ET were consecutively screened in the hematology department of our institution. Patients who underwent transthoracic echocardiography within 1 year of diagnosis were included in the study. A control group of healthy individuals matched for demographic characteristics was established. Second echocardiographic evaluation was performed during the follow-up period. The routine echocardiographic and strain parameters of both groups were compared.
Results:
A total of 92 participants were included, consisting of 60 patients with ET and 32 healthy volunteers. GLS values were reduced in the ET group compared to the control group (16.5 ± 2.4% vs. 22.5 ± 2.2%; p = 0.024). Among ET patients, those with GLS values ≤ 18% had a higher prevalence of the JAK2 mutation (81.1% vs. 21.7%; p < 0.001). In univariate logistic regression analysis, presence of the JAK2 mutation (OR: 4.6; 95% CI: 1.01-21; p = 0.04) was independently associated with reduced GLS.
Conclusions:
ET may reduce GLS, especially in the presence of JAK2 mutation.
More Related Videos
11:50High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart
Published on: July 9, 2010
07:21Magnetic Resonance Derived Myocardial Strain Assessment Using Feature Tracking
Published on: February 12, 2011
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests